HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk of cancer in the Norwegian aluminium industry.

Abstract
The study comprises 7,410 male employees from the Norwegian primary aluminium industry, and presents overall mortality as well as cancer incidence. During the period 1953-79, 428 new cases of cancer were observed compared to the expected number of 412.2. The only statistically significant difference for the four investigated plants combined was cancer of the lung with 57 observed against 35.9 expected cases. The increased risk was almost solely confined to two subgroups in processing departments; workers with a short duration of employment and workers with a very long duration of employment in the older plants. These results were difficult to interpret because of the problems in selecting the appropriate reference population for estimation of expected number of cases of lung cancer. Furthermore, the individual occupational histories were incomplete and there was no information on smoking habits. In order to determine whether there is an excess risk for workers with long periods of employment in the newer plants, it is necessary to wait for another 10-20 years, when more conclusive data will become available.
AuthorsA Andersen, B E Dahlberg, K Magnus, A Wannag
JournalInternational journal of cancer (Int J Cancer) Vol. 29 Issue 3 Pg. 295-8 (Mar 15 1982) ISSN: 0020-7136 [Print] United States
PMID7068278 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Aluminum
Topics
  • Aluminum (adverse effects)
  • Follow-Up Studies
  • Humans
  • Lung Neoplasms (chemically induced, mortality)
  • Male
  • Neoplasms (chemically induced, mortality)
  • Norway
  • Occupational Diseases (chemically induced, mortality)
  • Risk
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: